Aperio Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$1.15M Buy
21,163
+1,539
+8% +$83.7K ﹤0.01% 1521
2020
Q3
$390K Sell
19,624
-748
-4% -$14.9K ﹤0.01% 1954
2020
Q2
$428K Sell
20,372
-5,854
-22% -$123K ﹤0.01% 1842
2020
Q1
$321K Buy
26,226
+14,756
+129% +$181K ﹤0.01% 1866
2019
Q4
$168K Buy
+11,470
New +$168K ﹤0.01% 2220
2019
Q3
Sell
-5,044
Closed -$83K 2602
2019
Q2
$83K Buy
+5,044
New +$83K ﹤0.01% 2434